-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LDZmUD4SaM/T5vWvMAtgcqd2j5YCgA/NZaV6O4jpoz39iRhMs1GiFixN3saHbc5r ZRqKYV1CfG8oLrlKyrS/9w== 0001140361-11-002742.txt : 20110113 0001140361-11-002742.hdr.sgml : 20110113 20110113154916 ACCESSION NUMBER: 0001140361-11-002742 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20110113 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20110113 DATE AS OF CHANGE: 20110113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 11527580 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 8-K 1 form8k.htm CAMBREX CORP 8-K 1-13-2011 form8k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C.  20549
FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
 
 January 13, 2011
 
  

CAMBREX CORPORATION
(Exact name of Registrant as specified in its charter)

DELAWARE
 
1-10638
 
22-2476135
(State or other jurisdiction of incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)


ONE MEADOWLANDS PLAZA, EAST RUTHERFORD, NEW JERSEY
07073
(Address of principal executive offices)
   (Zip Code)

Registrant's telephone number, including area code:
 
(201) 804-3000
 


Check the appropriate box if the Form 8K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2 below):

 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(d) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 
 
CAMBREX CORPORATION
Form 8-K
Current Report
 
January 13, 2011
 
Section 5 – Corporate Governance and Management
Item 5.02.Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Cambrex is reporting under Item 5.02 (c) that Mr. Shawn P. Cavanagh was appointed Executive Vice President and Chief Operating Officer, effective January 17, 2011.  Mr. Cavanagh will assume leadership for Cambrex's innovator pharmaceutical contract manufacturing operations, including the related sales, marketing and R&D teams and Cambrex's biocatalysis business.  He will oversee and coordinate the Company's new product development programs, and will partner with Cambrex Zenara and Cambrex's generics leadership team to help grow those businesses. Mr. Cavanagh will also play an integral role in strategic planning and M&A activities.

As Executive Vice President and Chief Operating Officer, Mr. Cavanagh will (i) receive an annual base salary of $375,000 per year; (ii) participate in the Cambrex Executive Incentive Plan (EIP); (iii) participate in Cambrex's employee benefit plans, such as health, disability, life insurance and 401(k) plans; and (iv) in the event Cambrex chooses to relocate Mr. Cavanagh, Mr. Cavanagh will be entitled to relocation assistance including the reimbursement of standard relocation expenses as well as losses relating to the sale of his residence up to a maximum of $150,000.  In addition, Mr. Cavanagh entered into an employment agreement with Cambrex ("Employment Agreement") which provides, among other things, that in the event of a Change of Control (as defined in the Employment Agreement), Mr. Cavanagh would be awarded a two - -year contract of employment at substantially the same salary, bonus, and benefits as Mr. Cavanagh had prior to the start of such two-year term and including other benefits as defined in the Employment Agreement.

The foregoing description of Mr. Cavanagh's employment agreement is qualified in its entirety by reference to the Offer of Employment Letter and the Employment Agreement, which are attached to this current report on Form 8-K as Exhibit 10.1 and Exhibit 10.2, respectively.

 
 

 
 
On January 7, 2011, Cambrex issued a press release announcing Mr. Cavanagh’s appointment as Executive Vice President and Chief Operating Officer.  The press release is attached to this Form 8-K as Exhibit 99.1.


Item 9.01 - Financial Statements and Exhibits
(c)  Exhibits

(10)  Material Contracts
Exhibit 10.1 – Shawn Cavanagh Offer of Employment Letter
Exhibit 10.2 – Shawn Cavanagh Employment Agreement

(d)           Exhibits

(99.1)  Press release issued by Cambrex Corporation dated January 7, 2011

 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CAMBREX CORPORATION


Date:
January 13, 2011
 
By:
 /s/
F. Michael Zachara
 
       
Name:
F. Michael Zachara
 
       
Title:
Vice President, General Counsel and Corporate Secretary
 
 

EX-10.1 2 ex10_1.htm EXHIBIT 10.1 ex10_1.htm

EXHIBIT 10.1
January 6, 2011


Mr. Shawn Cavanagh
4805 Smokey Court
Frederick, MD

 
Dear Shawn:

The Cambrex management team has enjoyed working with you again and we look forward to your transition from a consultant to a full time Cambrex executive. We would like to extend an offer of employment to you to join the Company as Executive Vice President and Chief Operating Officer reporting to me, starting on January 17, 2011. You will receive an annual base salary at the rate of $375,000 per year.

Additionally, you will participate in the Company’s Executive Incentive Plan ("EIP"), the elements of which are determined by the Board of Directors annually.  For your information, the 2010 program included a targeted bonus award of 60% of base salary paid entirely in cash.  Metrics, corresponding targets, targeted payouts and the form of the payouts have not yet been set for 2011.  EIP bonus awards are paid out shortly after the finalization of the prior year's financial results.  Cambrex employees must be actively employed on the date the EIP bonus awards are paid.

Attached please find the Employment Agreement (the “Agreement”) between you and Cambrex Corporation, which shall become effective only in the event of a Change in Control as defined in the Agreement.  Should your employment with Cambrex be involuntarily terminated for reasons other than for Cause (see the definition of “Cause” in the Agreement) without the Agreement becoming effective, you will be entitled to receive a severance payment equal to your regular base salary for up to 12 months from your date of separation or until you find equivalent employment, if earlier.

We will recommend to the Cambrex Board of Directors a stock option grant of 75,000 shares of Cambrex stock at the next regularly scheduled Board of Directors Meeting.  The exercise price for these options will be the average of the high and low prices of Cambrex stock on the day the option grant is approved by the Board or, if later, the day your employment starts.  The stock options vest and are exercisable 25% per year over 4 years. In addition, we will recommend to the Board that you be entitled to earn up to a maximum of 50,000 performance share units as set forth in the attached draft Performance Share Agreement. Incentive based compensation will be subject to the Company’s claw back policy as required by the Dodd-Frank Act.

You will be eligible to participate in our Basic Life Insurance, Supplemental Life Insurance, Accidental Death and Dismemberment, Comprehensive Health, Flexible Spending, and Long Term Disability plans, commencing on the first day of active employment.  Additionally, you will be eligible to participate in the Cambrex Savings Plan/401(k) commencing on the first of the month following 30 days of active service.  Cambrex will match the first 6% of your contributions (100% on the first 3% and 50% on the next 3%) that you contribute to the Savings Plan and the Company match portion will vest immediately.
 
 
Cambrex Corporation | One Meadowlands Plaza | East Rutherford, NJ 07073
Phone 201.804.3005 | Fax 201.804.3380 | www.cambrex.com
 
 
 

 

At any time after one (1) year from the start of your employment, i.e., January 17, 2012, the Company may require you to relocate.  The Company shall provide you with twelve (12) months notice of a proposed relocation. If you have not relocated within 12 months of such notice, the Company shall be entitled to terminate your employment, effective twelve months (12) from the date of such notice, without the obligation to pay the aforementioned severance.  In the event of a Change in Control (as defined in the Agreement) prior to the completion of any relocation described within this Letter, for purposes of Section 5(c)(i) of the Agreement, your principal place of employment shall be considered to be 4805 Smokey Court, Frederick, MD until such time as you have relocated per the terms of this letter.  In the even t that the Company requires you to relocate, you will be entitled to relocation assistance as described in the attached Relocation Policy, which details the terms and conditions of the Company’s relocation program.  To the extent the terms, conditions and intent of this Letter conflict with the terms and conditions of the Relocation policy (including without limitation, the time period set forth in the Procedure for Purchase of Home, Temporary Living and Travel Expenses and Incidental Expenses), the terms and conditions of this Letter shall control to implement the purpose and intent hereof.

Additionally, in the event that a relocation results in a selling price that is lower than your investment in your home as of the date of this Letter, subject to verification at the time of reimbursement, the company will reimburse you for your losses up to a maximum amount of $150,000.  Any payment made to compensate you for any such losses will be grossed up for taxes consistent with section 5.0 in the Relocation Policy.  Note that any reimbursement of such losses will be subject to the same terms and conditions as any other reimbursed expense defined within the Relocation Policy.

You will be eligible for four (4) weeks vacation   In addition, Cambrex employees enjoy 12 holidays per year.  A more detailed description of our benefits is attached for your review.

Commencement of work with Cambrex Corporation is contingent upon proof of eligibility of U.S. employment, satisfactory references, a background check, and the execution of a Confidentiality Agreement.

Finally, commencement of work is also contingent upon the completion of a pre-employment physical examination relating to the essential functions of the job and a drug screen. Please contact Noreen Pattermann at 201-804-3054 to schedule your physical upon acceptance of this offer.

I look forward to your joining Cambrex as an integral member of our management team. Please feel free to call me should you have any questions or if we can assist you in any way.


Sincerely,


Cambrex Corporation

Please indicate your acceptance of this arrangement by signing below and returning one copy of this letter and the signed Employment Agreement to us.



Shawn Cavanagh
Enclosures
 
 
Cambrex Corporation | One Meadowlands Plaza | East Rutherford, NJ 07073
Phone 201.804.3005 | Fax 201.804.3380 | www.cambrex.com
 
 

EX-10.2 3 ex10_2.htm EXHIBIT 10.2 ex10_2.htm

EXHIBIT 10.2

EMPLOYMENT AGREEMENT
 
THIS AGREEMENT made by and between CAMBREX CORPORATION, a Delaware corporation (the "Company"), and Shawn Cavanagh, (the "Employee"), as of the 17th day of January, 2011.
 
WHEREAS, the Employee presently is a key management employee of the Company, namely its Executive Vice President & Chief Operating Officer; and
 
WHEREAS, the Board of Directors of the Company (the "Board"), on the advice of its Compensation Committee, has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication of the Employee, notwithstanding the possibility, threat, or occurrence of a Change of Control (as defined below) of the Company.  The Board believes it is imperative to diminish the inevitable distraction of the Employee by virtue of the personal uncertainties and risks created by a pending or threatened Change of Control, to encourage the Employee's full attention and dedication to the Company currently and in the event of any threatened or pending Change of Control which provides the Employee with individual financial securi ty and which are competitive with those of other corporations. In order to accomplish these objectives, the Board has caused the Company to enter into this Agreement.
 
NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:
 
1. Certain Definitions.
 
(a) The "Effective Date" shall be the first date during the "Change of Control Period" (as defined in Section 1(b)) on which a Change of Control occurs. Anything in this Agreement to the contrary notwithstanding, if the Employee's employment with the Company is terminated prior to the date on which a Change of Control occurs, and it is reasonably demonstrated that such termination (1) was at the request of a third party who has taken steps reasonably calculated to effect a Change of Control or (2) otherwise arose in connection with or anticipation of a Change of Control, then for all purposes of this Agreement the "Effective Date" shall mean the date immediately prior to the date of such termination.
 
(b) The "Change of Control Period" is the period commencing on the date hereof and ending on the second anniversary of such date; provided, however, that commencing on the date one year after the date hereof, and on each successive anniversary thereof (each such anniversary being hereinafter referred to as a "Renewal Date"), the Change of control Period shall be automatically extended so as to end on the third anniversary of such Renewal Date unless at least sixty (60) days prior to such Renewal date the Company shall give notice that the Change of Control Period shall not be so extended, in which event the then current Change of Control Period shall not be extended and shall end on the then applicable ending date.

 
 

 

2. Change of Control. For the purpose of this Agreement, a "Change of Control" shall mean:
 
(a) the acquisition (other than from the Company) by any person, entity or "group" (within the meaning of Section 13 (d)(3) or 14(d)(2) of the Securities Exchange Act of 1934 (the "Exchange Act") but excluding for this purpose the Company or its subsidiaries or any employee benefit plan of the Company or its subsidiaries which acquires beneficial ownership of voting securities of the Company) of "beneficial ownership" (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifteen percent (15%) or more of either the then outstanding shares of common stock or the combined voting power of the Company's then outstanding voting securities entitled to vote generally in the election of directors; or
 
(b) individuals who, as of the date hereof, constitute the Board (as of the date hereof the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided that any person becoming a member of the Board subsequent to the date hereof whose election or nomination for election by the Company's stockholders (other than an election or nomination of an individual whose initial assumption of office is in connection with an actual or threatened election contest relating to the election of the directors of the Company, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be, for purposes of this Agreement, considered a member of the Incumbent Board; or
 
(c) approval by the stockholders of the Company of either a reorganization, or merger, or consolidation, with respect to which persons who were the stockholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own more than fifty percent (50%) of the combined voting power entitled to vote generally in the election of directors of the reorganized, merged or consolidated entity's then outstanding voting securities, or a liquidation or dissolution of the Company, or the sale of all or substantially all of the assets of the Company; or
 
(d) the sale or disposition by the Company of all or substantially all of the assets of the Company; or
 
(e) any other event or series of events or which, notwithstanding any of the foregoing provisions of this Section 2 to the contrary, is determined by a majority of the Incumbent Board to constitute a Change of Control for the purposes of this Agreement.
 
3. Employment Period. The Company hereby agrees to employ the Employee, and the Employee hereby agrees to remain in the employ of the Company, for the period (the "Employment Period") commencing on the Effective Date and ending on the second anniversary of such date; provided, however, that if a Change of Control actually occurs but the Employee's employment is terminated by the Company other than for Cause (as defined in Section 5(b) hereof) prior to the occurrence of such Change of Control but within twelve (12) months after

 
 

 
 
(a)  the commencement of a tender offer for at least 15% of the Company's common stock by any person (other than the Company, one of its subsidiaries or any employee benefit plan sponsored or maintained by the Company or one of its subsidiaries) that has not been withdrawn on or before the date of such termination;
 
(b)  the commencement of a proxy contest intended to remove control of the Company's business from the Incumbent Board that has not been abandoned on or before the date of such termination; or
 
(c)  the execution of a definitive agreement to merge or otherwise consolidate the Company with or into another corporation or to sell a substantial portion of the Company's assets (in each case, other than a transaction involving only the Company and one or more corporations or other entities directly or indirectly owned and controlled by the Company) that is still binding on the parties thereto at the date of such termination;
 
the Effective Date of this Agreement shall be deemed to be the day immediately prior to the date of such termination and the date of such termination shall be deemed to be the Employee's Date of Termination (as defined in Section 5(e) hereof) for the purposes of this Agreement.
 
4. Terms of Employment.
 
(a) Position and Duties.
 
(i) During the Employment Period, (A) the Employee's position shall be at least commensurate in all substantial respects with the Employee's position with the Company and its subsidiaries during the ninety-day period immediately preceding the Effective Date and (B) the Employee's services shall be performed at the location where the Employee was employed immediately preceding the Effective Date or any office or location less than fifty (50) miles from such location.
 
(ii) During the Employment Period, the Employee agrees to devote reasonable attention and time during normal business hours to the business and affairs of the Company and, to the extent necessary to discharge the responsibilities assigned to the Employee hereunder, to use the Employee's reasonable best efforts to perform faithfully and efficiently such responsibilities. It is expressly understood and agreed that to the extent that any outside activities have been conducted by the Employee prior to the Effective Date, the continued conduct of such activities subsequent to the Effective Date shall not thereafter be deemed to interfere with the performance of the Employee's responsibilities to the Company.

 
 

 
 
(b) Compensation.
 
(i) Base Salary. During the Employment Period, the Employee shall receive a base salary ("Base Salary") at a monthly rate at least equal to the highest monthly base salary paid or payable to the Employee by the Company and its subsidiaries during the twelve-month period immediately preceding the month in which the Effective Date occurs. During the Employment Period, the Base Salary shall be reviewed at least annually and shall be increased at any time and from time to time as shall be substantially consistent with increases in base salary awarded in the ordinary course of business to other key employees of the Company and its subsidiaries. Any increase in Base Salary shall not serve to limit or reduce any other obligation to the Employee under this Agreement.
 
(ii) Annual Bonus. In addition to Base Salary, the Employee shall be eligible (but not entitled) to receive, for each fiscal year during the Employment Period, an annual bonus (an "Annual Bonus") (pursuant to any regular incentive bonus plan maintained by the Company) in cash, restricted stock, restricted stock units or other forms of remuneration on the same basis as with respect to the fiscal year immediately preceding the fiscal year in which the Effective Date occurs.
 
5. Termination.
 
(a) Death or Disability. This Agreement shall terminate automatically upon the Employee's death. If the Company determines in good faith that the Disability of the Employee has occurred (pursuant to the definition of "Disability" set forth below), it may give to the Employee written notice of its intention to terminate the Employee's employment. In such event, the Employee's employment with the Company shall terminate effective on the thirtieth (30th) day after receipt of such notice by the Employee (the "Disability Effective Date"), provided that, within the thirty (30) days after such receipt, the Employee shall not have returned to full-time performance of the Employee's duties. For purposes of this Agreement, "Disability" means disability which, at least twenty-six (26) weeks after its commencement, is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to the Employee or the Employee's legal representative (such agreement as to acceptability not to be withheld unreasonably).
 
(b) Cause. The Company may terminate the Employee's employment for "Cause". For purposes of this Agreement, "Cause" shall constitute either (i) personal dishonesty or breach of fiduciary duty involving personal profit; (ii) the commission of a criminal act related to the performance of duties, or the furnishing of proprietary confidential information about the Company to a competitor, or potential competitor or third party whose interests are adverse to those of the Company; (iii) habitual intoxication by alcohol or drugs during work hours; or (iv) conviction of a felony.
 
(c) Good Reason. The Employee's employment may be terminated by the Employee for Good Reason. For purposes of this Agreement, "Good Reason" means:

 
 

 
 
(i) relocation of the principal place at which the Employee's duties are to be performed to a location more than fifty (50) miles from the principal place where the Employee's duties were performed during the ninety-day period immediately preceding the Effective Date;
 
(ii) a substantial reduction in the Base Salary, or in the benefits or perquisites provided the Employee from those which pertained during the 90-day period immediately preceding the Effective Date;
 
(iii) a substantial reduction in the Employee's, responsibilities, authorities or functions from those which pertained during the 90-day period immediately preceding the Effective Date;
 
(iv) a substantial adverse change in the Employee's work conditions from those which pertained during the 90-day period immediately preceding the Effective Date; and
 
(v) any failure by the Company to comply with and satisfy Section II(c) of this Agreement.
 
 
(d) Notice of Termination. Any termination by the Company for Cause or by the Employee for Good Reason shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 12(b) of this Agreement. For purposes of this Agreement, a "Notice of Termination" means a written notice which (i) indicates the specific termination provision in this Agreement relied upon (ii) sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Employee's employment under the provision so indicated and (iii) if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the termination date (which date shall be not more than fifteen (15) days after the giving of such notice). Th e failure by the Employee to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason shall not waive any right of the Employee hereunder or preclude the Employee from asserting such fact or circumstance in enforcing his rights hereunder.
 
(e) Date of Termination. "Date of Termination" means the date of receipt of the Notice of Termination or any later date specified therein, as the case may be; provided, however, that (i) if the Employee's employment is terminated by the Company other than Cause or Disability, the Date of Termination shall be the date on which the Company notifies the Employee of such termination and (ii) if the Employee's employment is terminated by reason of death or Disability, the Date of Termination shall be the date of death of the Employee or the Disability Effective Date, as the case may be.
 
6. Obligation of the Company upon Termination.

 
 

 
 
(a) Death. If the Employee's employment is terminated by reason of the Employee's death, this Agreement shall terminate without further obligations to the Employee's legal representatives under this Agreement, other than those obligations accrued or earned and vested (if applicable) by the Employee as of the Date of Termination, including, for this purpose (i) the Employee's full Base Salary through the Date of Termination at the rate in effect on the Date of Termination or, if higher, at the highest rate in effect at any time from the ninety-day period preceding the Effective Date through the Date of Termination (the "Highest Base Salary"), (ii) the product of the Annual Bonus paid to the Employee for the last full fiscal year and a fraction, the numerator of which is the number of da ys in the current fiscal year through the Date of Termination, and the denominator of which is three hundred sixty-five (365) and (iii) any compensation previously deferred by the Employee (together with accrued interest thereon, if any) and not yet paid by the Company and any accrued vacation pay not yet paid by the Company (such amounts specified in clauses (i), (ii) and (iii) are hereinafter referred to as "Accrued Obligations"). All such Accrued Obligations shall be paid to the Employee's estate or beneficiary, as applicable, in a lump sum in cash within thirty (30) days of the Date of Termination. Anything in this Agreement to the contrary notwithstanding, the Employee's family shall be entitled to receive benefits at least equal to the most favorable benefits provided by the Company and any of its subsidiaries under such plans, programs, practices and policies relating to family death benefits, if any, in accordance with the most favorable plans, programs, practices and policies of the company and its subsidiaries in effect at any time during the ninety-day period immediately preceding the Effective Date or, if more favorable to the Employee and/or the Employee's family, as in effect on the date of the Employee's death with respect to other key employees of the Company and its subsidiaries and their families.
 
(b) Disability. If the Employee's employment is terminated by reason of the Employee's Disability, this Agreement shall terminate without further obligations to the Employee; other than those obligations accrued or earned and vested (if applicable) by the Employee as of the Date of Termination, including for this purpose, all Accrued Obligations. All such Accrued Obligations shall be paid to the Employee in a lump sum in cash within thirty (30) days of the Date of Termination. Anything in this Agreement to the contrary notwithstanding, the Employee shall be entitled after the Disability Effective Date to receive disability and other benefits at least equal to the most favorable of those provided by the Company and its subsidiaries to disabled employees and/or their families in accordan ce with such plans, programs, practices and policies of the Company and its subsidiaries in effect at any time during the ninety-day period immediately preceding the Effective Date or, if more favorable to the Employee and/or the Employee's family, as in effect at any time thereafter with respect to other key employees of the Company and its subsidiaries and their families.
 
(c) Cause; Other than for Good Reason. If the Employee's employment shall be terminated for Cause, this Agreement shall terminate without further obligations to the Employee other than the obligation to pay to the Employee the Highest Base Salary through the Date of Termination plus the amount of any compensation previously deferred by the Employee (together with accrued interest thereon, if any). If the Employee terminates employment other than for Good Reason, this Agreement shall terminate without further obligations to the Employee, other than those obligations accrued or earned and vested (if applicable) by the Employee through the Date of Termination, including for this purpose, all Accrued Obligations. All such Accrued Obligations shall be paid to the Employee in a lump sum in c ash within thirty (30) days of the Date of Termination.

 
 

 
 
(d) Good Reason; Other than for Cause or Disability. If, during the Employment Period, the Company shall terminate the Employee's employment other than for Cause, Disability, or death or if the Employee shall terminate his employment for Good Reason:
 
(i) the Company shall pay to the Employee in a lump sum in cash within thirty (30) days after the Date of Termination the aggregate of the following amounts:
 
A. to the extent not theretofore paid, the Employee's Highest Base Salary through the Date of Termination; and
 
B. the product of (x) the highest Annual Bonus earned by the Employee during the two fiscal years immediately preceding the Date of Termination, or, if higher, the Employee's Target Bonus after the date of this Agreement until an Annual Bonus has actually been earned and (y) a fraction, the numerator of which is the number of days in the current fiscal year through the Date of Termination and the denominator of which is three hundred sixty-five (365); and
 
C. the product of (x) a fraction, the numerator of which is twenty-four (24) minus the number of whole months the Employee has been employed by the Company following the first anniversary of the Effective Date and the denominator of which is twelve (12) and (y) the annualized Highest Base Salary; and
 
D. the product of (x) fraction, the numerator of which is twenty-four (24) minus the number of whole months the Employee has been employed by the Company following the first anniversary of the Effective Date and the denominator of which is twelve (12) and (y) the highest Annual Bonus earned by the Employee during two fiscal years immediately preceding the Date of Termination, provided that Employee's Annual Bonus under this Section after the date of this Agreement shall be his Target Bonus until an Annual Bonus has actually been earned; and
 
E. in the case of compensation previously deferred by the Employee, all amounts previously deferred (together with accrued interest thereon, if any) and not yet paid by the Company, and any accrued vacation pay not yet paid by the Company; and
 
F. for the remainder of the Employment Period, or such longer period as any plan, program, practice or policy may provide, the Company shall continue benefits to the Employee and/or the Employee's family at least equal to those which would have been provided to them as if the Employee's employment had not been terminated, in accordance with the most favorable employee benefit plans of the Company and its subsidiaries (including health insurance and life insurance) during the ninety-day period immediately preceding the Effective Date or, if more favorable to the Employee, as in effect at any time thereafter with respect to other key employees and their families; and

 
 

 
 
(ii) all outstanding equity awards shall immediately vest and, as applicable, become exercisable.
 
7. Non-exclusivity of Rights. Nothing in this Agreement shall prevent or limit the Employee's continuing or future participation in any benefit, bonus, incentive or other plans, programs, policies or practices, provided by the Company or any of its subsidiaries and for which the Employee may qualify, nor shall anything herein limit or otherwise affect such rights as the Employee may have under any stock option or other agreements with the Company or any of its subsidiaries. Amounts which are vested benefits or which the Employee is otherwise entitled to receive under any plan, policy, practice or program of the Company or any of its subsidiaries at or subsequent to the Date of Termination shall be payable in accordance with such plan, policy, practice or program provided, however, that in the event the terms of any such plan, policy, practice or program concerning the payment of benefits thereunder shall conflict with any provision of this Agreement, the terms of this Agreement shall take precedence but only if and to the extent the payment would not adversely affect the tax exempt status (if applicable) of any such plan, policy, practice or program and only if the Employee agrees in writing that such payment shall be in lieu of any corresponding payment from such plan, policy, practice or program.
 
8. Full Settlement. The Company's obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Employee or others. In no event shall the Employee be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Employee under any of the provisions of this Agreement. The Company agrees to pay, to the full extent permitted by law, all legal fees and expenses which the Employee may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company or others of the validity or enforceability of, or liability under, any pr ovision of this Agreement or any guarantee of performance thereof (including as a result of any contest by the Employee about the amount of any payment pursuant to Section 9 of this Agreement), plus in each case interest at the applicable Federal rate provided for in Section 7872(f)(2) of the Internal Revenue Code of 1986, as amended (the "Code").
 
9. Limitations on Payments to Employee.
 
(a)  Notwithstanding any contrary provisions in any plan, program or policy of the Company or in this Agreement, if it is determined that any payment or benefit provided to or for the benefit of Employee whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise ("Payments") would be subject to the excise tax imposed by the Code section 4999 ("Excise Tax"),  the Company shall reduce Employee's Payments to the extent necessary so that no portion thereof shall be subject to the Excise Tax.

 
 

 
 
(b)  The Company shall defend, indemnify and hold harmless Employee from any claims or liabilities resulting from or relating to its determinations under Section 9(a).
 
10. Non-competition. As a condition to receiving any benefits pursuant to this Agreement, the Employee agrees that during his period of employment and through the first anniversary of his Date of Termination, the Employee shall not engage in or become associated with any Competitive Activity. For purposes of this Section 10, a "Competitive Activity" shall mean any business or other endeavor that engages in any country in which the Company or its Affiliates have business operations in a business that directly or indirectly competes with all or any substantial part of any of the business in which the Company or its Affiliates is engaged at the time of the Employee's Date of Termination. The Employee shall be considered to have become "engaged" or "associated" with a Competitive Activity if he becomes involved as an owner, employee, officer, director, independent contractor, agent, partner, advisor, lender, or in any other capacity calling for the rendition of the Employee's personal services, either alone or with any individual, partnership, corporation or other organization that is engaged in a Competitive Activity and his involvement relates in any respect to the Competitive Activity of such entity; provided, however, that the Employee shall not be prohibited from owning less than two percent of any publicly traded corporation, whether or not such corporation is in competition with the Company. If, at any time, the provisions of this Section 10 shall be determined to be invalid or unenforceable, by reason of being vague or unreasonable as to area, duration or scope of activity, this Section 10 shall be considered divisible and shall become and be immediately amended to only such area, duration and scope of activity as shall be determined to be reasonable and enforceable by the court or ot her body having jurisdiction over the matter; and the Employee agrees that this Section 10 as so amended shall be valid and binding as though any invalid or unenforceable provision had not been included herein.
 
11. Confidential Information. The Employee shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its subsidiaries, and their respective businesses, which shall have been obtained by the Employee during the Employee's employment by the Company or any of its subsidiaries and which shall not be or become public knowledge (other than by acts by the Employee or his representatives in violation of this Agreement). After termination of the Employee's employment with the Company, the Employee shall not, without the prior written consent of the Company, communicate or divulge any such information, knowledge or data to anyone other than the Company and those designated by it. In no event shall an asserted violation of the provisions of this Section 11 constitute a basis for deferring or withholding any amounts otherwise payable to the Employee under this Agreement.
 
12. Successors.

 
 

 

(a) This Agreement is personal to the Employee and without the prior written consent of the Company shall not be assignable by the Employee otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by the Employee's legal representatives.
 
(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.
 
(c) The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. As used in this Agreement, "Company" shall mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise.
 
13. Miscellaneous.
 
(a) This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflict of laws. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect.
 
(b) All notices and other communications hereunder shall be in writing and shall be given by hand delivery to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows:
 
If to the Employee:
 
Mr. Shawn Cavanagh
_________________
_________________
 
 
If to the Company:
 
Cambrex Corporation
One Meadowlands Plaza
East Rutherford, N.J. 07073
Attention: General Counsel

 
 

 

or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice and communications shall be effective when actually received by the addressee.
 
(c) The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.
 
(d) The Company may withhold from any amounts payable under this Agreement such Federal, state or local taxes as shall be required to be withheld pursuant to any applicable law or regulation.
 
(e) The Employee's failure to insist upon strict compliance with any provision hereof shall not be deemed to be a waiver of such provision or any other provision thereof.
 
(f) This Agreement contains the entire understanding of the Company and the Employee with respect to the subject matter hereof. This agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.
 
(g) The Employee and the Company acknowledge that the employment of the Employee by the Company or any of its subsidiaries prior to the Effective Date is "at will", and, prior to the Effective Date, may be terminated by either the Employee or the employer at any time. Upon a termination of the Employee's employment or upon the Employee's ceasing to be an officer of the Company, in each case, prior to the Effective Date, there shall be no further rights under this Agreement.
 
(h) The Employee acknowledges that any payment made pursuant to this agreement may be subject to the Company’s claw back policy adopted pursuant to the Dodd-Frank Act.
 
14. Section 409A. Notwithstanding anything in this Agreement to the contrary, to the extent the Employee would otherwise be entitled to a payment during the six months beginning on the Date of Termination that would be subject to the additional tax imposed under Section 409A of the Code, (i) the payment will not be made to the Employee and instead will be made, at the election of the Company, either to a trust in compliance with Rev. Proc. 92-64 or an escrow account established to fund such payments (provided that such funds shall be at all times subject to the creditors of the Company and its affiliates) and (ii) the payment, together with interest thereon at the rate of "prime" plus 1%, will be paid to the Employee on the earlier of the six-month anniversary of Date of Termination or the Employee's death or disability (within the meaning of Section 409A of the Code). Similarly, to the extent the Employee would otherwise be entitled to any benefit (other than a cash payment) during the six months beginning on the Date of Termination that would be subject to the additional tax under Section 409A of the Code, the benefit will be delayed and will begin being provided (together, if applicable, with an adjustment to compensate the Employee for the delay, with such adjustment to be determined in the Company's reasonable good faith discretion) on the earlier of the six-month anniversary of the Date of Termination or the Employee's death or disability (within the meaning of Section 409A of the Code). The Company will establish the trust or escrow account, as applicable, no later than ten days following the Employee's Date of Termination. It is the intention of the parties that the payments and benefits to which the Employee could become entitled in connection with termination of employment under this Agreement comply with Section 409A of the Code. In the event that the parties determine that any such benefit or right does not so comply, they will negotiate  reasonably and in good faith to amend the terms of this Agreement such that it complies (in a manner that attempts to minimize the economic impact of such amendment on the Employee and the Company).
 
 
 

 
 
IN WITNESS WHEREOF, pursuant to the authorization from its Board of Directors, the Company has caused these presents to be executed in its name on its behalf, and the Employee has hereunto set his hand, all as of the day and year first above written.
 
 
CAMBREX CORPORATION
 
       
 
By:
   
       
       
   
Shawn Cavanagh
 
 
 

EX-99.1 4 ex99_1.htm EXHIBIT 99.1 ex99_1.htm

EXHIBIT 99.1
Logo
Innovation. Experience. Performance.


NEWS RELEASE

SHAWN P. CAVANAGH APPOINTED CHIEF OPERATING OFFICER OF CAMBREX

East Rutherford, NJ – January 7, 2011 – Cambrex Corporation (NYSE: CBM) announced today that, effective January 17, Shawn Cavanagh will join the Company as Executive Vice President and Chief Operating Officer, reporting to Steve Klosk, President and Chief Executive Officer.

Mr. Cavanagh will assume leadership for Cambrex’s innovator pharmaceutical contract manufacturing operations, including the related sales, marketing and R&D teams, Cambrex’s biocatalysis business and the integration of Cambrex Zenara.  He will directly oversee the Company’s new product development programs and partner with our generics leadership team to help grow our generic API business.  Mr. Cavanagh will also play an integral role in strategic planning and M&A activities.

Mr. Cavanagh was most recently at Lonza, where he was the President of Lonza Bioscience, a global business with over $200 million in annual revenues.  Mr. Cavanagh managed Cambrex Bioproducts since 2005, prior to Lonza’s purchase of that business from Cambrex in 2007, and held positions of increasing responsibility within that business over nearly 20 years.  He holds a degree in Chemical Engineering, graduating cum laude from the University of New Hampshire.

“We are excited to welcome Shawn back to Cambrex, as he significantly strengthens our leadership team and will allow us to more aggressively execute our plans for growth in existing and developing markets.  A key focus will be to accelerate our new product development activities, with a particular emphasis on utilizing our chemistry, biocatalysis and formulation technology platforms. Shawn has a strong track record in leading complex global businesses and delivering growth, having led our Bioproducts business during a period when it was introducing several new products each year and growing at double digit rates,” said Steve Klosk, President and CEO.
 
About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (“APIs”), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.

Contact:
Stephanie LaFiura
 
Investor Relations Associate
Phone:
201.804.3037
Email:
stephanie.lafiura@cambrex.com

 

GRAPHIC 5 logo.jpg LOGO begin 644 logo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`!5`2@#`2(``A$!`Q$!_\0` M'``!``(#`0$!``````````````8'!`4(`P(!_\0`/Q```0,$`0,#`04&`P4) M`````0(#!``%!A$A!Q(Q$T%1(A1"87&!"!8C,I&A%25B%S-C<:NC!_XST77_P`7E5LV'I*]%V*&OP+@)_L*JY:&S)I04J"12E*` M4I2@%*4H!2E*`4I2@%*4H!2E*`4I2@%*4H!2E*`4I2@%*4H!2L&\W>WV2"N; M=YL>%%1P77UA`W\#?D_@.:I_*^OD",IUC%K<[<%C@2I1++._D)_G4/S[?SK7 M'AO+]"*UH]SX_AIVK7XZKE?)NH>59* M"SU*Y*A'0HGQH:4H_ MEVBOR#>.L.7-H7`@6W&X:CM+\EDIL:RXI\8X_+\_L644_J95\/I9.F)!RW-\CNQ) MVY'CR3$CK'P4H.]?D1^E2:R=/,0LBD+MV.6QM]/(?6P'7=_/J+VK^]2JE95F MNO=0RTMUY:6VD`J6M1T M$@B):D%;15X`:2GET[V`1H>-=PJO^J74BX9 MU38UNI99CM\+GK*M)*O?M)UVH_(GG03AY/$;ZEAZ13KU/+?M_)S7E;^G@T.0+NUVO*4WN;*O M.0.K[$1VU^MZ*CSV`)^D*^4-C0]R""D>L#'I$J\LV.TM(NF0.*(<#:NZ-$UH M*VKPLI)^I7*`>!WD@U)9UG5T\Z1=U;[J M?D[)E2M(5!.HO4RSX7V15I7<+R[_`+JWQCM?.M%9Y[`=C7!)]@='69U5RW]S M,/D7%I`:WU?VZ\7%Q:V'7OJ M4TD%25+^.Y7//LD`#6R*UQXY4/+DX_ZRE4]]L\GB$=9LMCB2V];<9BK'TQU? MPW2GV)VAQ0/ZH/X"H_<)/5K`KO;A(F+OJ)CA;:9;)E-O+T3V':$K0=`G8T-` MG9T:Z-==;9:6ZZM"&T)*EK40`D#DDGV%?+8:>].0CTW-IVAP:/TG7@_!T*LN MIUS"U^A#Q_=[/*UO2I$!AVX14PY2T]SC"70[Z9^.X``G\O[^:_;E.BVV"_,N M$AN-$825N/.*[4H`]R:P\GR"VXS9W;G>I*8\1O0V1LJ4?"4@ MYZ]0NL-_N-Z#N&39EMM7I^G'[V&S]K4%*!<`6@D#?TZW]WG1V!TI:(CT&W,1 MY,Z1/>0-+DR`@+<._)"`$C\@!7+\R1;LRZV6&-CZ&UV)AV+'B(0T6T>@R/66 M.T@$#8<'(KJP5KU:F9B96O'Y_)7$VVVV?BE!*220`.23[5R[U(ZPWQ[)IZ\2 MO+L2SQD>DUV-,N!\IWW.@K0HZ).ASR$@^]6%UYR^2VW&PO'.YR]WP M`%:]'AE:JUO?"^WR5S6^).JK$E^U8U&-]N*WY#+`19(J39.GD4!<:"A7;(NRN[2$G1X"B!^`WQO7>/3H%B!O-V=S2ZQ&&8B%J1 M;8J$?PT*!UWI_P!*`.Q).R3W$\@&HQXHQ)YQ/QN>YMDL+$<:EW>X?4AD`-M`Z4\X>$H'XD_P!! MLG@&N=\1P[.\RE'.8$^WQ9TB0M;4B4LA1T.S:$^FL!`&TIWS].Q[&LNGA4WE MR:2_;9:Z:7;/)-DXYUM4A*OWNM*-@'M46]C\#J*1O\B:B;V6=3K-GT7&WK_' MNES+S2%1VV67&5]P"B%$-(6D!)))&B!S63G+?5/#[,BX7G+67(KCH8U%=!7W M*!(\LI^#X.ZGG0+&[:WBL3*'(KR[[YKC?96UMR75-MEHN)/UJ)4 MA9"4\(V!RHZT>"95USSPXECX@VUS_.[D"VSV$][#?A3NASO?"?E1WSVD545N ML743IO8IMWAQXMMB%"%2'5>@\[HD`).P3Y5X'ONL>FP^.^M;?&RV2_.E^2>C M&NMN_P#OA9_ZH_Z2M=T2S?,;]G+UKN]R1<[>RPZN0M3+2?2*5!*2A;:4[VKY MWL;(\5@8BKJ1U0M4H?O3'A68/&))6EE"72>Q*B$A"`2-+'WT[W5R]/\`"[7A M%D^P6I"EN+(7(DN`>H^KY/P!X"1P/S))MEN8EQ:3K[+@B$Z::WHD,Z4Q!A/R MYCR&8S""XZXLZ2A(&R3^E<^V7(NH_4:^7N9A5W%KLS+H#*)J&TI2"-!(5Z*R M5Z'USI+:RU$896@,A&A"$=RB>!W# MZ0#\UNNGUKO%LQ]DY/WP')*UE/:V=<-H"0$Z3XV!R=GX`DU89,S>Y27 MZI%YCW(3UDGW.T]/KE@SHA:=2XTE"MI]1*5`A:5`CM43X\@5`NEG41; M.*7C(<[R22_]GDF*S'6VRD+'IH6.Q"$)4I9)4/.@!OCDUF=;.H=H79KKBEJ2 MNZW5]EQ$@1ME$1*1W+6I0!V4@$D#QH]Q3JH-^SUBEFR6_7:1>XPEJMB&'&&' M""T5.%S:E)^]KTQH'CD[!XUTX\273NLB_G1G5/U$I)CCDS/^H=_>O$"YS<8Q M%Q2?10IIE;KJ`DT` M?T`K)`T`!X%*X\F3OX6D;3.A2E*R+"JK_:2N;\#IT(S'";E,;B.J]PCM6X?Z M^F$_DHU:E:+-\9B9=C4NSSR4(>`4AY(!4TXD[2L;^"/U&Q[UIAI1D55PBMIN M6DK^J]3)D]/*LW,M:.:9[I[.& M8O5O%!U&P^W7#')#3\J/N3$^H!$AM:?J1L_RDZ203[C1ULD:SHYU`BQ;9$Q# M+%&SWZW(2PRW.'H^NT.&PGNU]0&DZ]]`C>SKXL6'9[T\>=;Q6=`R"PD]PMTY MQ3#B.=GTSHI23SL["23OMWS4BG7ZW7=EN)G&"79LI'<42+4+FRE6N>U3`<_J M0FN1Z[/3^J?;7*_!JEY[N&6'NE5[:(&&L=HLMVF6LIX1&3H67K1;UI*56^SI#85L?>64@'7P M4J'P:M&>[(M=H_RZWR+D\T@(;CMN-H4K0T"5+*4@?/\`8'Q6RI6=Y7>M\+V+ M*4N"F+'@N09CF#M[ZIQ4IBPPDV^V-O(.>=[T+ M0I5GU%NG2\;\?@+&M:*0ZCXMEW4#,;7&EVMZ!B<5Y(*OM+)=(/\`O'>T+.CK MZ4^2`2=QG/<[O;9CV(L6>&"F*T[,8"U*5_,XH!9&SX`V=#X)->[">ML=EIB-#MC##: M0AMM"8P2A(&@``K@`>U7Q2MEU3[5/:M(IZ7G>V4G$Z79-EMVB7'JC>6I,:,/ MX=NA\)Y\A2@$A._?0)(T.X:JX9*C;[XI2`!\D< M"LNE99,M9-;X7M[%YA3P4CA6"Y%=NI\G*^H$!+*F].PVD/MN(2L'3:?I.](3 MR..5'N//F>=7;9<;W@-QM5F@KF3)9;0E(<0@(`6E14HJ4.-)]MG9''DB94J: MSU5J_CCX(4))KY*PZ"8W>\5L5V@7^!]E6[,^TM*#R'$K"FT((^DD@@M^_P`C M\:E^;R[[%L,A.+6U4V[.H4VRHNMH0PHCA:N\C8'G0!V1HZ'-2"E5K([OO:)4 MZ7:CF3%L*ZI8O.E3K1;(HG21VNR9#[#SAVKN5RI7WCHGYT/BI%(D]$V:JQ1KA;[(TFZREW.YA'>^XA*4! MQS7*4)X"4^PWKY)WLU66JN*E81E[*[M+9>IVM%?HP*UXK@5XM.,6AV3(FQ7(ZU!Q`??*D%(*E MK*0`-[T.!SH;X,-Z$87E.(Y--FMI_`I2E8%Q2E*`4I2@/.3'9E1W&)+3;S#@*5MN)"DJ!\@@\$57 M=VZ,XA,E"7;XTNRSDK[T2;5)4RIL_P"A)VA/Z)%612KQDJ/I>B'*?)`K?C&: MVI9$3.6[A&2GM;9N]J2\1^;C;C:B?Q.ZW#+^7-)"7K;8)"O=U%P>9W^2"RO7 M_J-26E2\CKE+_7\$=NN#6195S.A*MS*#_P`*5WC^Z4__`%6Q;4I205)[3\;W M7U2J,L*4I4`4I2@%*4H!2E*`4I2@%*4H!2E*`4I2@%*4H!2E*`4I2@%*4H!2 ME*`4I2@%*4H!2E*`4I2@%*4H!2E*`4I2@%*4H!2E*`4I2@%*4H!2E*`4I2@% <*4H!2E*`4I2@%*4H!2E*`4I2@%*4H!2E*`__V3\_ ` end
-----END PRIVACY-ENHANCED MESSAGE-----